We are live on ! Find out more
MIFH

Migdal Insurance & Financial Holdings Portfolio holdings

AUM $15.6B
1-Year Est. Return 71.29%
This Fund
S&P 500
This Quarter Est. Return
+20.27%
1 Year Est. Return
+71.29%
3 Year Est. Return
+173.57%
5 Year Est. Return
+196.76%
10 Year Est. Return
+800.33%
AUM
$8.47B
AUM Growth
+$1.27B
Cap. Flow
+$26.3M
Cap. Flow %
0.31%
Top 10 Hldgs %
39.44%
Holding
764
New
106
Increased
151
Reduced
309
Closed
117

Sector Composition

Rank Sector Weight
1 Technology 21.75%
2 Financials 9.43%
3 Consumer Discretionary 9.03%
4 Communication Services 6.41%
5 Healthcare 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PASG icon
276
Passage Bio
PASG
$14.8M
$274K ﹤0.01%
+536
New +$215K
MYGN icon
277
Myriad Genetics
MYGN
$309M
$273K ﹤0.01%
+13,782
New +$223K
GH icon
278
Guardant Health
GH
$22.2B
$272K ﹤0.01%
+2,109
New +$243K
GNMK
279
DELISTED
GenMark Diagnostics, Inc
GNMK
$272K ﹤0.01%
+18,659
New +$247K
SPLV icon
280
Invesco S&P 500 Low Volatility ETF
SPLV
$7.18B
$270K ﹤0.01%
4,820
-6,623
-58% -$364K
VRTX icon
281
Vertex Pharmaceuticals
VRTX
$133B
$270K ﹤0.01%
+1,142
New +$262K
TAL icon
282
TAL Education Group
TAL
$6.58B
$268K ﹤0.01%
3,754
+1,585
+73% +$114K
TECX
283
Tectonic Therapeutic
TECX
$720M
$268K ﹤0.01%
+1,601
New +$285K
CIEN icon
284
Ciena
CIEN
$61.2B
$267K ﹤0.01%
5,058
+1,821
+56% +$80.9K
ERTH icon
285
Invesco MSCI Sustainable Future ETF
ERTH
$138M
$261K ﹤0.01%
3,480
+1,380
+66% +$91.4K
EXAS
286
DELISTED
Exact Sciences
EXAS
$261K ﹤0.01%
1,969
-8,203
-81% -$992K
ALNY icon
287
Alnylam Pharmaceuticals
ALNY
$30B
$255K ﹤0.01%
+1,962
New +$262K
BDTX icon
288
Black Diamond Therapeutics
BDTX
$121M
$253K ﹤0.01%
+7,881
New +$259K
VLDR
289
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$253K ﹤0.01%
+11,080
New +$188K
LAB icon
290
Standard BioTools
LAB
$312M
$252K ﹤0.01%
+42,043
New +$276K
TXG icon
291
10x Genomics
TXG
$7.52B
$251K ﹤0.01%
1,772
-10,630
-86% -$1.54M
REGN icon
292
Regeneron Pharmaceuticals
REGN
$82.2B
$249K ﹤0.01%
+516
New +$279K
LMNX
293
DELISTED
Luminex Corp
LMNX
$247K ﹤0.01%
+10,681
New +$248K
LVS icon
294
Las Vegas Sands
LVS
$29.6B
$246K ﹤0.01%
4,123
-42,584
-91% -$2.27M
PTCT icon
295
PTC Therapeutics
PTCT
$6.06B
$245K ﹤0.01%
+4,011
New +$236K
DAL icon
296
Delta Air Lines
DAL
$59.1B
$240K ﹤0.01%
5,968
-73,029
-92% -$2.66M
CLLS
297
Cellectis
CLLS
$296M
$238K ﹤0.01%
+8,812
New +$198K
HLT icon
298
Hilton Worldwide
HLT
$72.6B
$238K ﹤0.01%
2,137
-177,863
-99% -$17.6M
BLUE
299
DELISTED
bluebird bio
BLUE
$237K ﹤0.01%
+423
New +$268K
TCRT icon
300
Alaunos Therapeutics
TCRT
$4.88M
$236K ﹤0.01%
+624
New +$248K

Similar funds

Migdal Insurance & Financial Holdings's Q4 2020 Portfolio in Review

As of Q4 2020, Migdal Insurance & Financial Holdings held 764 positions worth $8.47B, up 18% from $7.2B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Migdal Insurance & Financial Holdings's Q4 2020 filing shows 106 new, 151 increased, 309 reduced and 117 closed positions. Its largest new stake was State Street SPDR S&P Bank ETF: 4,235,863 shares worth $177M. The largest sale was KraneShares CSI China Internet ETF, an estimated $84.5M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Migdal Insurance & Financial Holdings's largest Q4 2020 buy was State Street SPDR S&P Bank ETF: 4,235,863 shares worth $177M.
  • Migdal Insurance & Financial Holdings added most to iShares Russell 2000 ETF in Q4 2020, an estimated $194M increase.
  • Migdal Insurance & Financial Holdings's biggest Q4 2020 reduction was KraneShares CSI China Internet ETF, cutting an estimated $84.5M.
  • Migdal Insurance & Financial Holdings fully exited Equinix in Q4 2020, selling an estimated $36M.
  • Migdal Insurance & Financial Holdings's ten largest holdings make up 39% of its $8.47B portfolio in Q4 2020.
  • Migdal Insurance & Financial Holdings opened 106 new positions and closed 117 in Q4 2020.
  • Migdal Insurance & Financial Holdings's portfolio value rose 18% quarter-over-quarter to $8.47B.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q4 2020, filed 8 Feb 2021.